Botanical complex · IJTCM 2022 clinical publication
Consolax®: non-irritating botanical complex; significant gut-microbiota and stool-consistency improvements in IJTCM 2022 study. Distributed by Biontera.
Consolax® is a naturally sourced botanical complex for the constipation-management research area that does not irritate the intestinal wall. Its clinical results were published in the peer-reviewed International Journal of Traditional & Complementary Medicine (IJTCM, 2022).[1]
The publication reports increased beneficial bacterial levels (p<0.0139), decreased pathogenic bacterial levels (p<0.004), improved stool consistency (p<0.0005) and significantly improved spontaneous complete bowel movement (p<0.0005); reduced inflammatory-marker levels further support the product's anti-inflammatory profile.
Stimulant laxatives (such as senna derivatives) act by directly stimulating the gut wall, raising tolerance and dependence questions in long-term use. Consolax®'s clinical profile is different: it supports physiological bowel movement by improving microbiota composition and stool consistency.
The study reported a favourable tolerability and safety profile in participants with imbalanced gut microbiota. This profile is distinctive for geriatric users, sensitive groups, and bowel-regularity formulations positioned as "stimulant-free". Compatibility with probiotic combinations also enables synbiotic product design.
Significant improvement in microbiota composition, stool consistency and spontaneous bowel movements; reduced inflammatory markers; no safety concerns reported. Controlled clinical study · Participants with imbalanced microbiota · Daily · Multi-visit protocol
Every shipment can be delivered with a 12-item technical documentation file on request:
Senna-like stimulant laxatives directly stimulate the gut wall. In its clinical study, Consolax® supported physiological movement by improving microbiota composition and stool consistency, with no irritation reported.
The IJTCM 2022 publication reports p<0.0005 improvements in stool consistency and spontaneous complete bowel movement; increased beneficial bacteria (p<0.0139), decreased pathogens (p<0.004) and reduced inflammatory markers.
Yes; its microbiota-friendly mechanism suits synbiotic combinations with probiotic strains ; including our Unique Biotech strain portfolio.
The multi-visit protocol reported a favourable tolerability profile; the protocol can be shared with your technical team for specific use scenarios.
Aegle marmelos (Bael) fruit extract · standardised to gallotannic acid + marmelosin
Read the full monograph
Curcuma longa L. · 20% curcuminoids · water-dispersible powder
Read the full monograph
Stabilised beta-carotene · BioFusion technology · IJRPS publication
Read the full monograph